Trial intelligence / Profile preview

Rapamycin and Cardiac Function in the Elderly (Substudy E)

NCT04742777Phase 2Active, not recruiting

Sponsor
UT Health San Antonio
Start
Feb 2022
Primary completion
Oct 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in aging, sponsored by UT Health San Antonio. Started Feb 2022; status: active, not recruiting.

02

Drugs

sirolimus
03

Conditions

aging

Beyond the preview

Go deeper on NCT04742777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04742777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call